Kimberly-Clark EBIT per Share
The EBIT per Share of Kimberly-Clark (KMB) as of Aug 17, 2026 is 7.47 USD. In the previous year, EBIT per Share was 9.60 USD — a change of -22.16% (lower).
Get this data via API
Financial Data API
EBIT per Share
7.47USD
YoY
-22.16%
Last updated:
EBIT per Share of Kimberly-Clark is 2026 7.47 USD. EBIT per Share of Kimberly-Clark was 2025 9.60 USD. It decreases by -22.16% lower compared to the previous year.
Access this data via the Eulerpool API
Kimberly-Clark Stock analysis
What does Kimberly-Clark do? Kimberly-Clark Corporation is an American company specializing in the production of hygiene and healthcare products. It was founded in 1872 by cousins John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck, and is headquartered in Irving, Texas, USA.
Kimberly-Clark has a wide portfolio of products offered in various segments. The company produces hygiene products such as tampons, pads, diapers, and wet wipes under brands like Huggies, Kotex, and Kleenex. It also offers professional hygiene products for schools, hospitals, and other facilities. Brands like Scott and KleenGuard can be found in this category.
The company is also active in the personal care products sector, offering brands like Cottonelle and Andrex, which produce toilet paper and wet wipes for personal use. Kimberly-Clark also manufactures nonwovens for disposable medical products used in hospitals, clinics, and doctor's offices.
Kimberly-Clark has introduced a number of innovations to the market that have changed the way people use hygiene products. One example is the concept of the disposable diaper, originally introduced as a template for hospital patients. After its success in capturing market share for baby diapers, it became an essential part of child rearing for parents.
The company has a strong marketing presence and utilizes platforms like social media and television advertising to promote its brands and products. Kimberly-Clark also partners with nonprofit organizations and initiatives, such as providing education on improved menstrual hygiene for young women and girls.
Kimberly-Clark has revenue of over $18 billion and is a Fortune 500 company. It employs approximately 40,000 people worldwide and has subsidiaries in multiple countries.
The company is committed to sustainability and strives to minimize its impact on the environment. It has set ambitious goals for recycling, water management, and CO2 reduction by 2030 to reduce its ecological footprint.
Overall, Kimberly-Clark is one of the leading companies in the hygiene industry with a strong focus on innovation, marketing, and sustainability.
Output:
Kimberly-Clark Corporation is an American company specializing in the production of hygiene and healthcare products. Kimberly-Clark is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Kimberly-Clark stock
EBIT per Share of Kimberly-Clark is 7.47 USD in 2026.
EBIT per Share of Kimberly-Clark changed from 9.60 USD to 7.47 USD, representing a -22.16% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Kimberly-Clark since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Kimberly-Clark
All Key Metrics — Kimberly-Clark
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth